Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
about
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Diversity and severity of adverse reactions to quinine: A systematic review.Proteasome inhibitor associated thrombotic microangiopathy.Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.[Hemolytic anemia].Thrombotic microangiopathy associated with Valproic acid toxicityThrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.Effective treatment of chemotherapy induced atypical Haemolytic Uraemic Syndrome: a case series of 7 treated patients.Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes.Ixazomib-induced thrombotic microangiopathy.Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.Thrombotic thrombocytopenic purpura possibly triggered by Graves' disease.Drug Induced Thrombotic Microangiopathy with Certolizumab PegolComplement-mediated thrombotic microangiopathy associated with lupus nephritisDrug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860
Q30276550-599427FB-C5A2-4D1B-9AB7-361E7F1E5678Q33429589-76DB1FC9-DA7E-45A9-BA24-D4ECA91DF1B3Q33432949-DBDBB5B3-83B5-47AC-A74A-BED930D39B30Q33705135-132E07C8-A9B8-442F-9049-2684689682D1Q41070320-41B91994-03D0-4075-B573-0E159ADCD1B3Q41247102-3367C67E-052B-4C2C-9A79-AE0D2721FB60Q42368351-67973382-E3E7-47D2-AF03-E4738672AE19Q46032407-3610DB7B-F599-4712-85B0-9E658FB99578Q47841893-307E3CB2-78A3-4F14-B1FE-0A8A2CA9AE40Q48299809-6D98469D-E5B3-4EF3-B9BF-49C5BC7F3885Q50224262-A7DE9CA6-0C93-4CD3-AD05-96D108A59D8EQ55346941-2FC02159-3F8C-4CCD-8DFA-8A863D0C0934Q58704884-DCC3A8CE-7E21-4AB5-8731-1F7537E2B642Q58727886-CEEEA2AB-CB44-46E7-9597-26B4C436B090Q58805821-C0C45367-3B27-408C-ACA0-92C4C9B39C65
P2860
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@ast
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@en
type
label
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@ast
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@en
prefLabel
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@ast
Drug-induced thrombotic microa ...... the BloodCenter of Wisconsin.
@en
P2093
P2860
P50
P356
P1476
Drug-induced thrombotic microa ...... d the BloodCenter of Wisconsin
@en
P2093
Daniel W Bougie
James N George
Jessica A Reese
Richard H Aster
P2860
P304
P356
10.1002/AJH.23960
P577
2015-02-25T00:00:00Z